Sarah Almond of Mission Therapeutics joins us to discuss deubiquitinating enzymes, how they influence therapeutic development for neurodegenerative conditions, and their future contributions to drug discovery.
- 3 ай бұрын
Mission Therapeutics: Inhibiting DUBs to Halt Diseases | Vital Science Podcast: S5, E07
- Рет қаралды 178
Пікірлер